Search
for
Sort by
Research 61–90 of 1000+
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Evidence for the off-label use of tofacitinib in alopecia areata
- Journal of Population Therapeutics and Clinical Pharmacology
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Targeted immunotherapy for hair regrowth and regeneration
- Baricitinib: A Review in Severe Alopecia Areata
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review